Acadia Healthcare Provides Business Outlook Ahead of Investor Day
08 December 2022 - 12:00AM
Business Wire
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) will host its
first Investor Day beginning at approximately 9:00 a.m. Eastern
Time today, Wednesday, December 7, 2022, in New York City.
During the event, members of Acadia’s management team will
provide an overview of the Company’s behavioral healthcare services
and review Acadia’s growth strategy and financial outlook. The
Company will affirm its previously issued guidance for 2022 and
provide initial guidance for 2023, as follows:
2022
Guidance Range
2023
Guidance Range
Revenue
$2.58 to $2.60 billion
$2.79 to $2.86 billion
Adjusted EBITDA (1)
$595 to $605 million
$630 to $680 million
Adjusted earnings per diluted share
(1)
$3.00 to $3.10
$3.10 to $3.45
(1) Excluding income from provider relief
fund
“We are excited to provide a comprehensive overview of our
operations and to review our growth strategy with our investors,”
said Chris Hunter, Chief Executive Officer of Acadia Healthcare.
“Our financial guidance reflects Acadia’s solid execution to date
in 2022 and our current expectations for continued momentum into
the future. Demand for our services remains strong, and we are
uniquely positioned to meet the critical need for behavioral
healthcare treatment with enterprise capabilities that extend
across 246 facilities offering diversified service lines and
patient-centered care. We are mindful of the critical role we play
as an industry leader, and we believe we have the right strategy in
place to continue to extend our market reach and make a positive
difference in more communities. We are proud of the important work
we are doing and look forward to highlighting the opportunities
ahead for Acadia.”
The investor day presentation will be available to investors via
a live webcast. A link to the webcast is posted on the investor
relations section of the Company’s website at
https://www.acadiahealthcare.com/investors/event-calendar, and a
replay will be available for 90 days.
About Acadia Healthcare Company, Inc.
Acadia is a leading provider of behavioral healthcare services
across the United States. Acadia operates a network of 246
behavioral healthcare facilities with approximately 10,800 beds in
39 states and Puerto Rico. With more than 22,500 employees serving
approximately 75,000 patients daily, Acadia is the largest
stand-alone behavioral healthcare company in the U.S. Acadia
provides behavioral healthcare services to its patients in a
variety of settings, including inpatient psychiatric hospitals,
specialty treatment facilities, residential treatment centers and
outpatient clinics.
Non-GAAP Financial Information
The Company is not able to provide a reconciliation of projected
Adjusted EBITDA and adjusted earnings per diluted share, where
provided and whether including or excluding income from provider
relief fund, to expected results due to the unknown effect, timing
and potential significance of transaction related expenses and the
tax effect of such expenses.
Forward-Looking Information
This press release contains forward-looking statements.
Generally, words such as “may,” “will,” “should,” “could,”
“anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,”
and “believe” or the negative of or other variation on these and
other similar expressions identify forward-looking statements.
These forward-looking statements are made only as of the date of
this press release. We do not undertake to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise. Forward-looking statements are based on
current expectations and involve risks and uncertainties and our
future results could differ significantly from those expressed or
implied by our forward-looking statements. Factors that may cause
actual results to differ materially include, without limitation,
(i) the impact of general economic and employment conditions,
including increased labor, construction and other costs; (ii) the
impact of the COVID-19 pandemic on our inpatient and outpatient
admissions and volumes, or disruptions caused by other pandemics,
epidemics or outbreaks of infectious diseases; (iii) potential
difficulties in successfully integrating the operations of acquired
facilities or realizing the expected benefits and synergies of our
facility expansions, acquisitions, joint ventures and de novo
transactions; (iv) Acadia’s ability to add beds, expand services,
enhance marketing programs and improve efficiencies at its
facilities; (v) potential reductions in payments received by Acadia
from government and third-party payors; (vi) the occurrence of
patient incidents, governmental investigations, litigation and
adverse regulatory actions, which could adversely affect the price
of our common stock and result in substantial payments and
incremental regulatory burdens; (vii) the risk that Acadia may not
generate sufficient cash from operations to service its debt and
meet its working capital and capital expenditure requirements;
(viii) potential disruptions to our information technology systems
or a cybersecurity incident; and (ix) potential operating
difficulties, changes in client preferences, competition and
general industry conditions that may prevent Acadia from realizing
the expected benefits of its business strategies. These factors and
others are more fully described in Acadia’s periodic reports and
other filings with the SEC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20221207005301/en/
Gretchen Hommrich Vice President, Investor Relations
InvestorRelations@acadiahealthcare.com (615) 861-6000
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Acadia Healthcare (NASDAQ:ACHC)
Historical Stock Chart
From Apr 2023 to Apr 2024